{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:48:55Z","timestamp":1785041335949,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000848","name":"Cancer Research UK Development Fund (University of Edinburgh)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000858","name":"Breast Cancer","doi-asserted-by":"publisher","award":["Now - 2014NovPhD390"],"award-info":[{"award-number":["Now - 2014NovPhD390"]}],"id":[{"id":"10.13039\/501100000858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.canlet.2019.02.032","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T11:29:20Z","timestamp":1550489360000},"page":"76-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pharmacological inhibition of the IKK\u03b5\/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer"],"prefix":"10.1016","volume":"450","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-4798","authenticated-orcid":false,"given":"Ryan T.","family":"Bishop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane V.","family":"Lefley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9082-3665","authenticated-orcid":false,"given":"Andrew H.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4826-0771","authenticated-orcid":false,"given":"Penelope D.","family":"Ottewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-5306","authenticated-orcid":false,"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.02.032_bib1","doi-asserted-by":"crossref","unstructured":"B. Hoesel, J.A. Schmid, The complexity of NF-\u039ab signaling in inflammation and cancer, Mol. Canc. 2013, pp. 86.","DOI":"10.1186\/1476-4598-12-86"},{"key":"10.1016\/j.canlet.2019.02.032_bib2","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1128\/MCB.17.7.3629","article-title":"Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth","volume":"17","author":"Nakshatri","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.02.032_bib3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.biocel.2004.09.006","article-title":"Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers","volume":"37","author":"Zhou","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2019.02.032_bib4","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1158\/0008-5472.CAN-08-0107","article-title":"The NF-\u03baB pathway controls progression of prostate cancer to androgen independent growth","volume":"68","author":"Jin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.02.032_bib5","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/1078-0432.CCR-08-1383","article-title":"Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth","volume":"15","author":"Sakamoto","year":"2009","journal-title":"Clin. Cancer Res. : Official J. Amer. Assoc. Canc. Res."},{"key":"10.1016\/j.canlet.2019.02.032_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2007.03.052","article-title":"Integrative genomic approaches identify IKBKE as a breast cancer oncogene","volume":"129","author":"Boehm","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.02.032_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3321-6","article-title":"Detection of IKK\u03b5 by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis","volume":"17","author":"Williams","year":"2017","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.02.032_bib8","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1172\/JCI75661","article-title":"Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth","volume":"124","author":"Barbie","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2019.02.032_bib9","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1074\/jbc.M109.078212","article-title":"IKK\u03b5 phosphorylation of estrogen receptor \u03b1 Ser-167 and contribution to tamoxifen resistance in breast cancer*","volume":"285","author":"Guo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.032_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tibs.2008.01.002","article-title":"Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?","volume":"33","author":"Chau","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2019.02.032_bib11","doi-asserted-by":"crossref","first-page":"55633","DOI":"10.1074\/jbc.M409825200","volume":"279","author":"Buss","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.032_bib12","doi-asserted-by":"crossref","first-page":"37389","DOI":"10.1074\/jbc.M111.287433","article-title":"IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase\/PDK1\/mTORC2 and the pleckstrin homology domain to sustain malignant transformation","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.032_bib13","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1128\/MCB.00468-12","article-title":"I\u03baB kinase \u03b5 phosphorylates TRAF2 to promote mammary epithelial cell transformation","volume":"32","author":"Shen","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.02.032_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molcel.2009.04.031","article-title":"Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation","volume":"34","author":"Hutti","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2019.02.032_bib15","article-title":"IKBKE phosphorylation and inhibition of FOXO3a: a mechanism of IKBKE oncogenic function","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.02.032_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-6-179","article-title":"Clinical management of women with metastatic breast cancer: a descriptive study according to age group","volume":"6","author":"Manders","year":"2006","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.02.032_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jbmr.2026","article-title":"TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation","volume":"29","author":"Sun","year":"2014","journal-title":"J. Bone Miner. Res. : Official J. Amer. Soc. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2019.02.032_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/rheumatology\/ker154","article-title":"Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis","volume":"51","author":"Hammaker","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.canlet.2019.02.032_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.2008.095356","article-title":"Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta","volume":"68","author":"Corr","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.canlet.2019.02.032_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/art.22421","article-title":"Antiviral gene expression in rheumatoid arthritis: role of IKKepsilon and interferon regulatory factor 3","volume":"56","author":"Sweeney","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.canlet.2019.02.032_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1\/IKK\u03b5 improves obesity-related metabolic dysfunctions","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.02.032_bib22","doi-asserted-by":"crossref","first-page":"13575","DOI":"10.1038\/srep13575","article-title":"Amlexanox suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.02.032_bib23","first-page":"25","article-title":"A review of systemic treatment in metastatic triple-negative breast cancer","volume":"10","author":"Zeichner","year":"2016","journal-title":"Breast Canc. (Auckl)"},{"key":"10.1016\/j.canlet.2019.02.032_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bone.2003.07.012","article-title":"In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells","volume":"34","author":"Rucci","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2019.02.032_bib25","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jbmr.1847","article-title":"Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis","volume":"28","author":"Logan","year":"2013","journal-title":"J. Bone Miner. Res. : Official J. Amer. Soc. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2019.02.032_bib26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1541-7786.MCR-07-0119","article-title":"Osteoactivin promotes breast cancer metastasis to bone","volume":"5","author":"Rose","year":"2007","journal-title":"Mol. Canc. Res. : MCR"},{"key":"10.1016\/j.canlet.2019.02.032_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-61779-415-5_3","article-title":"Rat osteoblast cultures","volume":"816","author":"Orriss","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2019.02.032_bib28","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jbmr.1847","article-title":"Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis","volume":"28","author":"Logan","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2019.02.032_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/bonekey.2014.65","article-title":"Generation and culture of osteoclasts","volume":"3","author":"Marino","year":"2014","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.canlet.2019.02.032_bib30","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1210\/en.2008-0150","article-title":"Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor","volume":"149","author":"Idris","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2019.02.032_bib31","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.649608","article-title":"Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer-induced osteolysis","volume":"290","author":"Sophocleous","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.032_bib32","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","article-title":"Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo","volume":"8","author":"Idris","year":"2009","journal-title":"Mol. Canc. Ther."},{"key":"10.1016\/j.canlet.2019.02.032_bib33","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2010-0930","article-title":"The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation","volume":"152","author":"Sophocleous","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2019.02.032_bib34","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0511319103","article-title":"Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway","volume":"103","author":"Korherr","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.02.032_bib35","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.4161\/cc.6.18.4721","article-title":"Inhibition of the canonical IKK\/NF kappa B pathway sensitizes human cancer cells to doxorubicin","volume":"6","author":"Tapia","year":"2007","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.canlet.2019.02.032_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pros.22591","article-title":"Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer","volume":"73","author":"Codony-Servat","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2019.02.032_bib37","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1073\/pnas.1316255111","article-title":"Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer","volume":"111","author":"Wei","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.02.032_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.02.032_bib39","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","article-title":"Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo","volume":"8","author":"Idris","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2019.02.032_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41598-017-18327-5","article-title":"TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis","volume":"8","author":"Peramuhendige","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.02.032_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2017.09.034","article-title":"Pharmacological evidence for the bone-autonomous contribution of the NFkappaB\/beta-catenin axis to breast cancer related osteolysis","volume":"410","author":"Marino","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.02.032_bib42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.02.032_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.02.032_bib44","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nm.2007","article-title":"Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis","volume":"15","author":"Zhao","year":"2009","journal-title":"Nat. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:42:23Z","timestamp":1759592543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":44,"alternative-id":["S0304383519301107"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.032","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of the IKK\u03b5\/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}